GE Healthcare buys out Microsoft's 50% stake in healthcare startup Caradigm
Taylor Soper / GeekWire :
Context & Ripple Effects
Caradigm was a 50/50 joint venture between GE and Microsoft aimed at hospital data analytics; this buyout ends the shared-ownership structure and hands GE full control. The split did not end the relationship — four years later the two companies would jointly launch a cloud-based COVID-19 patient monitoring tool for hospitals, suggesting the JV gave way to a looser vendor partnership.
First-order effects
- GE Healthcare now owns Caradigm outright, letting it fold the startup into its own software roadmap instead of negotiating product direction with Microsoft.
Second-order effects
- Microsoft, no longer a co-owner, pivots to selling its own healthcare offerings directly — a move visible two years later when it launched services including Microsoft Genomics and an AI-based Empower MD platform (four new services for healthcare professionals).
Third-order effects
- The buyout fits GE's steady consolidation of healthcare IT in-house — from the Wise.io machine-learning acquisition months after this deal to its $2.3B purchase of Intelerad's cloud imaging and workflow tools nearly a decade later — while big tech retreats from JV equity toward cloud and services deals, a shift also seen in Samsung's acquisition of Xealth's digital-health management platform.
The trend: Healthcare IT is consolidating around acquirer-owned software platforms, with big tech shifting from joint-venture stakes to arms-length cloud and services relationships.